Our President has zero authority to "give" any drug to anyone...the monoclonal antibody testing is ongoing as to efficacy, safety and dosage...the FDA would need to approve any authorizations for this drug or any drug..
Trials began in June...he received it under the "compassionate use" provision...only 275 patients to date...while a few thousand have signed up for the trial DJT may have hindered the testing as people may be reluctant to take a placebo when they think they could get the real thing..it is possible this cocktail of two different antibodies (which does show promise) may receive the Emergency Use Authorization (EUA) as Rendesivir was given..
We still do not know the true health of President Trump or what, if any, therapy has helped him..time will tell (and soon)..as for it being dispersed for "free" I think Regeneron will have something to say about that...
Have a nice, safe, fun weekend all..
Mark
News 
Market Data 
Discover 
